Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Gastrointestinal Neoplasms × regorafenib × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 45 Neoplasms 13 Neoplasm Metastasis 12 Gastrointestinal Stromal Tumors 8 Glioblastoma 5 Colonic Neoplasms 5 Carcinoma, Hepatocellular 5 Stomach Neoplasms 3 Sarcoma 3 Ovarian Neoplasms 3 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Pancreatic Neoplasms 2 Liver Neoplasms 2 Gallbladder Neoplasms 2 Esophageal Neoplasms 2 Colorectal Cancer Metastatic 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bile Duct Neoplasms 2 Advanced Cancer 2 Wilms Tumor 1 Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer) 1 Thymoma 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Solid Tumor 1 Sarcoma, Ewing 1 Renal Insufficiency 1

Interventions

Oxaliplatin 11 Fluorouracil 10 Surveys and Questionnaires 8 Leucovorin 8 Cisplatin 8 Capecitabine 8 Irinotecan 7 Bevacizumab 6 Standard of Care 5 Gemcitabine 5 Drug Therapy 4 S 1 (combination) 3 Radiotherapy 3 Interviews as Topic 3 Educational Status 3 Cyclophosphamide 3 trebananib 2 tivozanib 2 pembrolizumab 2 Taxes 2 Remote Patient Monitoring 2 Pemetrexed 2 Panitumumab 2 Ocoxin 2 Nivolumab 2 N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2 Mitomycin 2 Mass Screening 2 MLN 8237 2 Interleukin-2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02386397 2026-03-12

BREGO

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1/2 Completed

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡